Hearing impairment-associated KARS mutations lead to defects in aminoacylation of both cytoplasmic and mitochondrial tRNALys
- 13 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Science China Life Sciences
- Vol. 63 (8), 1227-1239
- https://doi.org/10.1007/s11427-019-1619-x
Abstract
Aminoacyl-tRNA synthetases (aaRSs) are ubiquitously expressed, essential enzymes, synthesizing aminoacyl-tRNAs for protein synthesis. Functional defects of aaRSs frequently cause various human disorders. Human KARS encodes both cytosolic and mitochondrial lysyl-tRNA synthetases (LysRSs). Previously, two mutations (c.1129G>A and c.517T>C) were identified that led to hearing impairment; however, the underlying biochemical mechanism is unclear. In the present study, we found that the two mutations have no impact on the incorporation of LysRS into the multiple-synthetase complex in the cytosol, but affect the cytosolic LysRS level, its tertiary structure, and cytosolic tRNA aminoacylation in vitro. As for mitochondrial translation, the two mutations have little effect on the steady-state level, mitochondrial targeting, and tRNA binding affinity of mitochondrial LysRS. However, they exhibit striking differences in charging mitochondrial tRNALys, with the c.517T>C mutant being completely deficient in vitro and in vivo. We constructed two yeast genetic models, which are powerful tools to test the in vivo aminoacylation activity of KARS mutations at both the cytosolic and mitochondrial levels. Overall, our data provided biochemical insights into the potentially molecular pathological mechanism of KARS c.1129G>A and c.517T>C mutations and provided yeast genetic bases to investigate other KARS mutations in the future.Keywords
This publication has 47 references indexed in Scilit:
- Aminoacylation and translational quality control strategy employed by leucyl-tRNA synthetase from a human pathogen with genetic code ambiguityNucleic Acids Research, 2013
- Mutations in LARS2, Encoding Mitochondrial Leucyl-tRNA Synthetase, Lead to Premature Ovarian Failure and Hearing Loss in Perrault SyndromeAmerican Journal of Human Genetics, 2013
- Role of tRNA amino acid-accepting end in aminoacylation and its quality controlNucleic Acids Research, 2011
- Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndromeProceedings of the National Academy of Sciences of the United States of America, 2011
- Compound Heterozygosity for Loss-of-Function Lysyl-tRNA Synthetase Mutations in a Patient with Peripheral NeuropathyAmerican Journal of Human Genetics, 2010
- Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cellsNature Protocols, 2009
- The CP2 Domain of Leucyl-tRNA Synthetase Is Crucial for Amino Acid Activation and Post-transfer EditingOnline Journal of Public Health Informatics, 2008
- Aminoacyl tRNA synthetases and their connections to diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Crystal structure of tetrameric form of human lysyl-tRNA synthetase: Implications for multisynthetase complex formationProceedings of the National Academy of Sciences of the United States of America, 2008
- Charcot–Marie–Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defectProceedings of the National Academy of Sciences of the United States of America, 2007